{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:59:05Z","timestamp":1790492345265,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.tmaid.2006.04.004","type":"journal-article","created":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T07:31:42Z","timestamp":1150788702000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["A review of the long-term protection after hepatitis A and B vaccination"],"prefix":"10.1016","volume":"5","author":[{"given":"Pierre","family":"Van Damme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Herck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2006.04.004_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mpd.2001.116277","article-title":"Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan","volume":"139","author":"Kao","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmaid.2006.04.004_bib2","doi-asserted-by":"crossref","unstructured":"European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000;355:561\u20135.","DOI":"10.1016\/S0140-6736(99)07239-6"},{"key":"10.1016\/j.tmaid.2006.04.004_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8278(88)80032-1","article-title":"Persistence of specific antibodies after hepatitis B vaccination","volume":"6","author":"Jilg","year":"1988","journal-title":"J Hepatol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2893.2003.00400.x","article-title":"Hepatitis B vaccine\u2014do we need boosters?","volume":"10","author":"Banatvala","year":"2003","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.tmaid.2006.04.004_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1017922302854","article-title":"Assessment of long-term efficacy of hepatitis B vaccine","volume":"17","author":"Ayerbe","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib6","first-page":"168","article-title":"Ten-year serological follow-up of hepatitis B vaccine recipients","volume":"19","author":"Chadha","year":"2000","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0264-410X(00)00224-3","article-title":"Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory","volume":"19","author":"Banatvala","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(05)67568-X","article-title":"Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study","volume":"366","author":"Zanetti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2006.04.004_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/345871","article-title":"Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan","volume":"187","author":"Lin","year":"2003","journal-title":"J Inf Dis"},{"key":"10.1016\/j.tmaid.2006.04.004_bib11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1542-3565(04)00384-2","article-title":"18 year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children","volume":"2","author":"Yuen","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","article-title":"Antibody levels and protection after hepatitis B vaccination: results of a 15 year follow-up","volume":"142","author":"McMahon","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2006.04.004_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0270-9139(95)95021-4","article-title":"Long-term immunity to hepatitis B infection after vaccination with recombinant hepatitis B vaccine","volume":"22","author":"Boland","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.tmaid.2006.04.004_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jmv.1890350313","article-title":"A prospective study of in vitro anti-HBs producing B cells (Spot-ELISA) following primary and supplementary vaccination with recombinant hepatitis B vaccine in insulin-dependent diabetic patients and matched controls","volume":"35","author":"Wismans","year":"1991","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib15","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/S0264-410X(02)00356-0","article-title":"Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres","volume":"20","author":"Dentico","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib16","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","article-title":"Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants","volume":"23","author":"FitzSimons","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.7326\/0003-4819-142-5-200503010-00014","article-title":"Long-term protection of hepatitis B vaccine: lessons learnt from Alaskan experience after 15 years","volume":"142","author":"Chen","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2006.04.004_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jama.294.2.246","article-title":"Effect of hepatitis A vaccination programs","volume":"294","author":"Van Damme","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2006.04.004_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jmv.10574","article-title":"Hepatitis A Vaccine: Indirect Evidence of Immune Memory 12 Years After the Primary Course","volume":"72","author":"Van Herck","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib20","unstructured":"Van Herck K, Renard D, Molenberghs G, Van Damme P. Model-based estimates of long-term persistence of vaccine induced hepatitis A antibodies. In: Margolis H, Alter M, Liang T, Dienstag J, editors. Viral Hepatitis and Liver Diseases. Proceedings of the Tenth International Symposium on Viral Hepatitis and Liver Diseases, 9\u201313 April 2000, Atlanta, USA. International Medical Press, Atlanta, USA; 2002. p. 56\u20139."},{"key":"10.1016\/j.tmaid.2006.04.004_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jmv.10244","article-title":"Long-term immunogenicity of an inactivated virosome hepatitis A vaccine","volume":"68","author":"Bovier","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10096-003-1094-0","article-title":"Aventis Pasteur vaccines containing inactivated hepatitis A virus: a compilation of immunogenicity data","volume":"23","author":"Vidor","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2006.04.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<1::AID-JMV1>3.0.CO;2-H","article-title":"Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines","volume":"60","author":"Van Herck","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0264-410X(00)00188-2","article-title":"Inactivated hepatitis A vaccine booster given \u2a7e24 months after the primary dose","volume":"19","author":"Landry","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2310\/7060.2004.17079","article-title":"Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine","volume":"11","author":"Iwarson","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2006.04.004_bib26","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/S0264-410X(03)00250-0","article-title":"Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults","volume":"21","author":"Williams","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/378890","article-title":"Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis a vaccine","volume":"37","author":"Beck","year":"2003","journal-title":"CID"},{"key":"10.1016\/j.tmaid.2006.04.004_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2310\/7060.2004.19002","article-title":"Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine","volume":"11","author":"Beck","year":"2004","journal-title":"J Travel Med"},{"issue":"Suppl. 1","key":"10.1016\/j.tmaid.2006.04.004_bib29","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/0264-410X(92)90572-2","article-title":"Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees","volume":"10","author":"Purcell","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib30","series-title":"The immune response to hepatitis A vaccination: studies in vivo and in vitro","author":"Chen","year":"1996"},{"issue":"Suppl. 2","key":"10.1016\/j.tmaid.2006.04.004_bib31","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0168-8278(05)80372-1","article-title":"Immunologic approaches to assessing the response to inactivated hepatitis A vaccine","volume":"18","author":"Lemon","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","article-title":"Consensus Statement: hepatitis A booster vaccination: is there a need?","volume":"362","author":"Van Damme","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2006.04.004_bib33","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0264-410X(98)00421-6","article-title":"The first combined vaccine against hepatitis A and B: an overview","volume":"17","author":"Thoelen","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jmv.1094","article-title":"Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults","volume":"65","author":"Van Damme","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib35","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1016\/S0264-410X(01)00240-7","article-title":"A prospective, randomized, comparative US trial of a combined hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix) in adults","volume":"19","author":"Joines","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1586\/14760584.3.3.249","article-title":"A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine","volume":"3","author":"Van Damme","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tmaid.2006.04.004_bib37","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1086\/433182","article-title":"Hepatitis A and B booster recommendations: implications for travelers","volume":"41","author":"Zuckerman","year":"2005","journal-title":"CID"},{"key":"10.1016\/j.tmaid.2006.04.004_bib38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/00006454-200011000-00004","article-title":"Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody","volume":"19","author":"Dagan","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2006.04.004_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.inf.0000059446.52063.b9","article-title":"Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose","volume":"22","author":"Fiore","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2006.04.004_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0264-410X(98)00200-X","article-title":"Long-term follow-up of hepatitis A vaccination in children","volume":"17","author":"Chan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0264-410X(97)00179-5","article-title":"Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years","volume":"16","author":"Fan","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.04.004_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<235::AID-JMV13>3.0.CO;2-B","article-title":"Duration of protection from clinical hepatitis A disease after vaccination with VAQTA","volume":"49","author":"Wiens","year":"1996","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2006.04.004_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/14760584.4.4.459","article-title":"Prevention of hepatitis A by Havrix: a review","volume":"4","author":"Van Herck","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tmaid.2006.04.004_bib44","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2006.01.007","article-title":"Comparative immunogenicity of a PreS\/S hepatitis B vaccine in non- and low responders to conventional vaccine","volume":"24","author":"Rendi-Wagner","year":"2006","journal-title":"Vaccine"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893906000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893906000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:56:42Z","timestamp":1761487002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893906000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1477893906000664"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2006.04.004","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the long-term protection after hepatitis A and B vaccination","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2006.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}